Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment

Triple-negative breast cancer (TNBC) is associated with a high rate of early recurrence and distant metastasis, frequent development of therapeutic resistance, and a poor prognosis. There is a lack of targeted therapies for this aggressive subtype of breast cancer. Identifying novel effective treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Bowen, Chen, Jiongyu, Han, Bingchen, Zhang, Xinfeng, Hao, Jijun, Giuliano, Armando E., Cui, Yukun, Cui, Xiaojiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843598/
https://www.ncbi.nlm.nih.gov/pubmed/33510281
http://dx.doi.org/10.1038/s41598-021-82128-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843598/
https://www.ncbi.nlm.nih.gov/pubmed/33510281
http://dx.doi.org/10.1038/s41598-021-82128-0

Ejemplares similares